Table 1.
Patient demographics, baseline subjective score, and parameters
| Successful (n=58) | Failure (n=161) | Univariate P |
Multivariate P |
Odds ratio (Exp 95% range) | |
|---|---|---|---|---|---|
| Male (%) | 44 (26.2) | 124 (73.8) | 0.858 | 1.000 | 0.000 (0.000-) |
| Female (%) | 14 (27.5) | 37 (72.5) | |||
| Age | 71.5 ± 12.7 (38-94) | 72.3 ± 11.3 (24-96) | 0.661 | 0.598 | 0.981 (0.912-1.054) |
| IPSS-V | 5.25 ± 5.24 | 5.55 ± 5.27 | 0.703 | 0.982 | 0.998 (0.873-1.142) |
| IPSS-S | 4.84 ± 2.09 | 4.11 ± 2.19 | 0.031 | 0.915 | 1.027 (0.625-1.690) |
| IPSS-T | 10.1 ± 6.00 | 9.66 ± 6.15 | 0.649 | - | - |
| OABSS | 3.21 ± 0.67 | 2.91 ± 1.00 | 0.037 | 0.639 | 0.772 (0.262-2.278) |
| USS | 0.00 ± 0.00 | 0.01 ± 0.16 | 1.000 | - | - |
| PPBC | 2.67 ± 1.80 | 2.51 ± 1.68 | 0.542 | 0.339 | 1.327 (0.743-2.372) |
| QoL-I | 2.77 ± 1.17 | 2.77 ± 1.23 | 0.976 | 0.755 | 0.863 (0.342-177) |
| Nocturia/day | 3.81 ± 0.95 | 3.09 ± 1.32 | 0.000 | 0.046 | 2.223 (1.014-4.875) |
| Qmax | 12.6 ± 7.76 | 11.8 ± 8.29 | 0.536 | 0.534 | 1.039 (0.920-1.174) |
| VoL | 198.9 ± 129.7 | 186.5 ± 139.2 | 0.567 | 0.695 | 0.998 (0.991-1.006) |
| PVR | 64.4 ± 79.0 | 61.4 ± 80.7 | 0.809 | 0.821 | 1.001 (0.991-1.011) |
| TPV | 39.0 ± 17.3 | 43.8 ± 23.5 | 0.359 | 0.300 | 0.980 (0.943-1.018) |
| TZI | 40.0 ± 12.2 | 38.5 ± 17.1 | 0.697 | 0.437 | 6.711 (0.055-817.23) |
P<0.05 considered significant difference. IPSS: International Prostate Symptom Score, IPSS-V: IPSS voiding subscore; IPSS-S: IPSS storage subscore, IPSS-T: IPSS total score, QoL-I: Quality of life index, OABSS: Overactive Bladder Symptom Score, USS: Urgency Severity Scale, PPBC: Patient perception of bladder condition, Qmax: Maximum flow rate, Vol: Voided volume, PVR: Postvoid residual volume, TPV: Total prostate volume; TZI: Transition zone index